Effectiveness of oxaliplatin desensitization protocols-Reference-Cited by-同舟云学术

Effectiveness of oxaliplatin desensitization protocols

Published:2012-07-25 Issue:3 Volume:15 Page:219-225
ISSN:1699-048X
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Cortijo-Cascajares Susana,Nacle-López Inmaculada,García-Escobar Ignacio,Aguilella-Vizcaíno María José,Herreros-de-Tejada Alberto,Cortés-Funes Castro Hernán,Calleja-Hernández Miguel-Ángel

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12094-012-0909-9.pdf

Reference32 articles.

1. Lee C, Gianos M, Klaustermeyer WB (2009) Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents. Ann Allergy Asthma Immunol 102:179–187

2. Syrigou E, Syrigos K, Saif MW (2008) Hypersensitivity reactions to oxaliplatin and other antineoplastic agents. Curr Allergy Asthma Rep 8:56–62

3. Pagani M (2010) The complex clinical picture of presumably allergic side effects to cytostatic drugs: symptoms, pathomechanism, reexposure, and desensitization. Med Clin North Am 94:835–852

4. Polyzos A, Tsavaris N, Gogas H, Souglakos J, Vambakas L, Vardakas N et al (2008) Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience. Oncology 76:36–41

5. Medioni J, Coulon MA, Morere JF, Hennebelle F, Piperno-Neumann S, Breau JL (1999) Anaphylaxis after oxaliplatin. Ann Oncol 10:610

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the efficacy of a premedication regimen including high-dose cetirizine in reduction of hypersensitivity reactions to paclitaxel: A retrospective cohort study;Journal of Oncology Pharmacy Practice;2024-07-23

2. Leucovorin-induced Hypersensitivity Reaction in a Patient with Metastatic Colorectal Cancer Treated with Cetuximab Plus FOLFOX Chemotherapy: A Case Report;The Korean Journal of Gastroenterology;2023-12-25

3. Rechallenge After Oxaliplatin-Induced Hypersensitivity Reactions;JAMA Oncology;2023-03-01

4. Desensitization for the prevention of drug hypersensitivity reactions;The Korean Journal of Internal Medicine;2022-03-01

5. High concentration of oxaliplatin may be a risk factor for vascular pain;Journal of Clinical Pharmacy and Therapeutics;2021-11-07